Omnicell (NASDAQ: OMCL) releases FY and Q4 2025 results

Rhea-AI Filing Summary

Omnicell, Inc. filed a current report stating it issued a press release on February 5, 2026 announcing its financial results for the quarter and year ended December 31, 2025. The press release is provided as Exhibit 99.1 and is furnished, rather than filed, under securities laws.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0000926326false00009263262026-02-052026-02-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  February 5, 2026

OMNICELL, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-33043

94-3166458

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification Number)

4220 North Freeway

Fort Worth, TX 76137

(Address of principal executive offices, including zip code)

(877) 415-9990

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, $0.001 par value

OMCL

NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company									☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On February 5, 2026, Omnicell, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2025. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number						Exhibit Description
99.1						Press release entitled “Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results” dated February 5, 2026
104						Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

			OMNICELL,  INC.
Date: February 5, 2026			/s/ H. Baird Radford, III
			Baird Radford
			Executive Vice President and Chief Financial Officer

FAQ

What did Omnicell (OMCL) disclose in its latest 8-K filing?

Omnicell disclosed that it issued a press release announcing financial results for the quarter and year ended December 31, 2025. The full text of this press release is attached as Exhibit 99.1 and incorporated by reference in the current report.

When did Omnicell (OMCL) release its fiscal year 2025 financial results?

Omnicell released its fiscal year and fourth quarter 2025 financial results on February 5, 2026. On that date, the company issued a press release covering the period ended December 31, 2025, and furnished it to investors through a current report.

Where can investors find Omnicell’s FY and Q4 2025 results?

Investors can find Omnicell’s fiscal year and fourth quarter 2025 results in the press release attached as Exhibit 99.1. This exhibit is part of the current report, which incorporates the full text of the financial results announcement by reference.

How does Omnicell classify the information about its 2025 results?

Omnicell classifies the financial results information as furnished, not filed, under the Securities Exchange Act of 1934. This means the press release in Item 2.02 and Exhibit 99.1 is not subject to certain liability provisions that apply to filed information.

Who signed Omnicell’s current report covering 2025 results?

The current report was signed on behalf of Omnicell by H. Baird Radford, III. He is identified as the company’s Executive Vice President and Chief Financial Officer, acting as the duly authorized officer for this financial results disclosure.